This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 May;17(5):543-4.

doi: 10.1016/S1470-2045(16)00079-6. Epub 2016 Mar 18.

Lung cancer CT screening: is annual screening necessary?

John K Field¹, Stephen W Duffy²

Affiliations

Affiliations

¹ Roy Castle Lung Cancer Research Programme, University of Liverpool, The Apex Building, Liverpool L7 8TX, UK. Electronic address: j.k.field@liv.ac.uk.
² Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

PMID: 27009071
DOI: 10.1016/S1470-2045(16)00079-6

Comment

Lung cancer CT screening: is annual screening necessary?

John K Field et al. Lancet Oncol. 2016 May.

. 2016 May;17(5):543-4.

doi: 10.1016/S1470-2045(16)00079-6. Epub 2016 Mar 18.

Authors

John K Field¹, Stephen W Duffy²

Affiliations

¹ Roy Castle Lung Cancer Research Programme, University of Liverpool, The Apex Building, Liverpool L7 8TX, UK. Electronic address: j.k.field@liv.ac.uk.
² Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

PMID: 27009071
DOI: 10.1016/S1470-2045(16)00079-6

No abstract available

PubMed Disclaimer

Comment on

Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
Patz EF Jr, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR. Patz EF Jr, et al. Lancet Oncol. 2016 May;17(5):590-9. doi: 10.1016/S1470-2045(15)00621-X. Epub 2016 Mar 18. Lancet Oncol. 2016. PMID: 27009070 Free PMC article. Clinical Trial.

Similar articles

Cure Rate of Lung Cancer Diagnosed at Annual CT Screening.
Grenier PA. Grenier PA. Radiology. 2023 Nov;309(2):e232698. doi: 10.1148/radiol.232698. Radiology. 2023. PMID: 37934092 No abstract available.
Computed tomographic screening for lung cancer: the Mayo Clinic experience.
Gillaspie EA, Allen MS. Gillaspie EA, et al. Thorac Surg Clin. 2015 May;25(2):121-7. doi: 10.1016/j.thorsurg.2014.11.001. Epub 2015 Jan 28. Thorac Surg Clin. 2015. PMID: 25901556 Review.
Incidental renal tumours on low-dose CT lung cancer screening exams.
Pinsky PF, Dunn B, Gierada D, Nath PH, Munden R, Berland L, Kramer BS. Pinsky PF, et al. J Med Screen. 2017 Jun;24(2):104-109. doi: 10.1177/0969141316657115. Epub 2016 Oct 9. J Med Screen. 2017. PMID: 28482765 Clinical Trial.
Re: Lung cancer screening: did we really need a randomized controlled trial?
Wood DE. Wood DE. Eur J Cardiothorac Surg. 2016 Jul;50(1):34-5. doi: 10.1093/ejcts/ezw105. Epub 2016 Mar 25. Eur J Cardiothorac Surg. 2016. PMID: 27016197 No abstract available.
Low-dose CT screening for lung cancer reduced lung cancer mortality in Hitachi City.
Nawa T. Nawa T. Int J Radiat Biol. 2019 Oct;95(10):1441-1446. doi: 10.1080/09553002.2018.1511930. Epub 2018 Oct 11. Int J Radiat Biol. 2019. PMID: 30307383 Review.

See all similar articles

Cited by

Lung cancer screening strategy for non-high-risk individuals: a narrative review.
Fu F, Zhou Y, Zhang Y, Chen H. Fu F, et al. Transl Lung Cancer Res. 2021 Jan;10(1):452-461. doi: 10.21037/tlcr-20-943. Transl Lung Cancer Res. 2021. PMID: 33569326 Free PMC article. Review.
Identification of Candidates for Longer Lung Cancer Screening Intervals Following a Negative Low-Dose Computed Tomography Result.
Robbins HA, Berg CD, Cheung LC, Chaturvedi AK, Katki HA. Robbins HA, et al. J Natl Cancer Inst. 2019 Sep 1;111(9):996-999. doi: 10.1093/jnci/djz041. J Natl Cancer Inst. 2019. PMID: 30976808 Free PMC article.
Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer.
Carvalho AS, Cuco CM, Lavareda C, Miguel F, Ventura M, Almeida S, Pinto P, de Abreu TT, Rodrigues LV, Seixas S, Bárbara C, Azkargorta M, Elortza F, Semedo J, Field JK, Mota L, Matthiesen R. Carvalho AS, et al. Sci Rep. 2017 Feb 7;7:42190. doi: 10.1038/srep42190. Sci Rep. 2017. PMID: 28169345 Free PMC article.
Optimizing the lung cancer screening interval: the world is waiting.
Ridge CA, Boiselle PM. Ridge CA, et al. J Thorac Dis. 2016 Oct;8(10):E1369-E1370. doi: 10.21037/jtd.2016.10.25. J Thorac Dis. 2016. PMID: 27867631 Free PMC article. No abstract available.
Reconsidering lung cancer screening: is biannual screening possible?
Ruano-Ravina A, Fernandez-Villar A, Provencio-Pulla M. Ruano-Ravina A, et al. J Thorac Dis. 2016 Sep;8(9):2372-2375. doi: 10.21037/jtd.2016.09.30. J Thorac Dis. 2016. PMID: 27746979 Free PMC article. No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information